MedPath

A. Menarini Hong Kong Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

PPB:59

Drug Approvals

QUOFENIX POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG

Approval Date
Dec 15, 2024
PPB

ORSERDU TABLETS 345MG

Approval Date
Dec 15, 2024
PPB

QUOFENIX TABLETS 450MG

Approval Date
Dec 15, 2024
PPB

ORSERDU TABLETS 86MG

Approval Date
Dec 15, 2024
PPB

VABOREM POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/1G

Approval Date
Apr 30, 2024
PPB

ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000MCG/1ML

Approval Date
Dec 11, 2023
PPB

SPEDRA TABLETS 100MG

Approval Date
Aug 31, 2023
PPB

SPEDRA TABLETS 50MG

Approval Date
Aug 31, 2023
PPB

SPEDRA TABLETS 200MG

Approval Date
Aug 31, 2023
PPB

GIBITER EASYHALER INHALATION POWDER 160MCG/4.5MCG PER INHALATION

Approval Date
Mar 31, 2020
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.